Table 2 Characteristics of the subject classified by ED severity

n

68

138

47

Age, years

48 ± 17

61 ± 13^a

72 ± 7^a,b

Height, cm

170.2 ± 6.2

167.1 ± 6.6^a

165.2 ± 6.0^a

Body mass, kg

66.8 ± 11.7

64.5 ± 8.2

63.0 ± 9.9

Body mass index, kg/m²

23.0 ± 3.5

23.1 ± 2.5

23.0 ± 2.9

Total cholesterol, mg/dL

202 ± 37

209 ± 36

212 ± 43

HDL cholesterol, mg/dL

64 ± 17

64 ± 15

63 ± 17

LDL cholesterol, mg/dL

116 ± 33

121 ± 34

123 ± 32

Triglycerides, mg/dL

98 ± 50

107 ± 63

115 ± 50

Glucose, mg/dL

99 ± 20

103 ± 13^a

109 ± 29^a

HbA1c, mg/dL

5.4 ± 0.6

5.5 ± 0.5^a

57 ± 0.6^a

Testosterone, nmoL/L

22.2 ± 7.4

20.9 ± 5.5

20.8 ± 10.1

Heart rate, bpm

58 ± 8

60 ± 11

61 ± 8

Aortic AP, mmHg

9 ± 7

12 ± 7^a

15 ± 6^a,b

Aortic AP_HR75, mmHg

5 ± 5

8 ± 5^a

11 ± 4^a,b

Aortic AI, %

24 ± 15

31 ± 13^a

35 ± 8^a

Aortic AI_HR75, %

16 ± 15

24 ± 11^a

29 ± 7^a,b

Time to reflection, ms

149 ± 18

138 ± 17^a

131 ± 17^a,b

Smoking, n (%)^c

5 (7.4)

7 (5.1)

4 (8.5)

 Antihypertensive, n (%)^c

7 (10.3)

40 (29.0)

20 (42.6)

 Antihypercholesterolemic, n (%)^c

4 (5.9)

20 (14.5)

10 (21.3)

 Antihyperglycemic, n (%)^c

2 (2.9)

5 (3.6)

7 (14.9)

 Angina, n (%)^c

1 (1.5)

5 (3.6)

1 (2.1)

 Myocardial infarction, n (%)^c

1 (1.5)

0 (0)

2 (4.3)

 Stroke, n (%)^c

0 (0)

4 (2.9)

2 (4.3)